Hims & Hers Health Inc. Chief Executive Officer Andrew Dudum sold 660,000 Class A common shares on 7 August at an average price of $50.58, generating roughly $33.6 million, according to a Form 4 filed with the U.S. Securities and Exchange Commission. The transaction represents the largest insider sale in the San Francisco-based telehealth company’s history, filings show. Dudum’s divestment follows a sharp rally in Hims & Hers shares this year, though the filing did not disclose the executive’s remaining stake or his reasons for the sale.